Comparison of the effects of vaginal hyoscine butylbromide and misoprostol on cervical preparation for gynecological intrauterine interventions: a double-blind clinical trial

Read full text Summarise with VIRAT
Authors: Mahshid Khakzad, Safa Mousavi, Sadra Sarandili, Majid Mirmohammadkhani, Shahrzad Aghaamoo
Cited by: 0
References: 11

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Effective cervical preparation is crucial for procedures requiring transcervical uterine access. Insufficient dilation can complicate these interventions. While chemical agents are commonly used, the optimal method remains under investigation. Objective: This study aimed to compare the effectiveness and safety of vaginal hyoscine butylbromide vs vaginal misoprostol for cervical preparation prior to gynecological intrauterine surgery. Methods: This double-blind, randomized controlled trial included 71 women scheduled for gynecological intrauterine interventions requiring cervical preparation. Participants were randomly assigned to receive either vaginal hyoscine butylbromide (n=36, 40 mg total dose) or vaginal misoprostol (n=35, 200 µg) 2 to 4 hours before the procedure. The primary outcome was the diameter of the first Hegar dilator that could be inserted through the internal os without resistance. Secondary outcomes included cervicovaginal-uterine complications and drug-related side effects. Results:

Fields of Study & Subjects

Reproductive Health and Contraception Gynecological conditions and treatments Maternal and Perinatal Health Interventions

Publication details

Journal / source
AJOG Global Reports
Volume
6
Issue
2
Pages
100626–100626
Publication date
25 March 2026
Language
EN